Navigation Links
Christopher Codeanne Appointed Chief Financial Officer of Premier Research Group
Date:12/16/2010

PHILADELPHIA, Dec. 16, 2010 /PRNewswire/ -- Premier Research Group Limited, the international pharmaceutical and medical device services company, announces the appointment of Christopher Codeanne to the position of Chief Financial Officer.

Mr. Codeanne has more than 20 years of management, operational, and finance and accounting experience. Prior to joining Premier Research, he was the Chief Operating Officer and Chief Financial Officer of Oncology Development Partners, LLC (d/b/a Oncopartners).  He has also served as the Chief Financial Officer of both Averion International Corp and SCIREX Corporation. Mr. Codeanne serves as a member of the Board of Directors of Cornerstone Therapeutics Inc., a specialty pharmaceutical company.

Mr. Codeanne received an MBA with a concentration in finance from the University of Connecticut and a Bachelor of Science degree in Accounting from Fairfield University. He is a member of the American Institute of Certified Public Accountants, Connecticut Society of Certified Public Accountants and Financial Executives International.  

"We are pleased to have Chris join Premier Research as our Chief Financial Officer. He is a seasoned leader with a proven track record in the industry," said Dr. Ludo Reynders, CEO. "With his skill set and experience, he will be instrumental in directing the finances of the company while facilitating our growth strategy."

About Premier Research
Premier Research is a leading global solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. With a network of skilled staff operating across North America and Europe and partnerships in Latin America, Asia, South Africa, Australia and the Middle East, Premier Research manages Phase 1-4 trials and programs.

They are leaders in clinical research for analgesia, oncology, neuroscience, and cardiovascular and have a wealth of experience in medical device and pediatric research. They offer a comprehensive selection of services for every phase of clinical development including, regulatory affairs, clinical trial management, clinical research centers, medical affairs and strategic consulting, pharmacovigilance, data operations, biostatistics, medical writing, IVRS/IWRS, quality assurance, and functional sourcing.

www.premier-research.com


'/>"/>
SOURCE Premier Research Group Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial
2. IDEV Technologies Names Christopher M. Owens President, Chief Executive Officer
3. Pfizers Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts
4. David Feldman, M.D. Appointed Co-Principal Investigator of DuraHeart(TM) Left Ventricular Assist System U.S. Clinical Trial
5. Autism Spectrum Therapies Co-Founder and Chief Clinical Officer Dr. William Frea Appointed to Board of Directors of Los Angeles Chapter of Autism Speaks
6. Wound Management Technologies Completes Acquisition of Secure eHealth, LLC and Other Assets from VirtualHealth Technologies; Robert Tapales Appointed President of Secure eHealth, LLC
7. VirtualHealth Technologies Completes Sale of Secure eHealth, LLC and Other Assets to Wound Management Technologies; Robert Tapales Appointed President of Secure eHealth, LLC
8. Clive Dix Appointed as Chairman of Crescendo Biologics
9. Ruediger Naumann-Etienne Appointed to IRIDEX Board of Directors
10. Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger
11. Pharmaceutical Industry Veteran is Appointed CMO at Kinex Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... , 23. Januar 2017  ResMed (NYSE: ... und 3B Medical ( Winter Haven, Florida ... Vereinbarung über die Beilegung aller globalen Rechtsstreitigkeiten zwischen den ... Verkauf ihrer bestehenden Produkte im Tausch gegen Lizenzgebühren ... an 3B leisten, um das in Florida ...
(Date:1/23/2017)... , Jan. 23, 2017 Just two weeks remain until ... intellectual property, gather in Central London to discuss ... its kind in the market, Parallel Trade 2017 . ... preliminary list of attendees which is available to read in the event ... ...
(Date:1/21/2017)... PUNE, India , January 20, 2017 ... by Type (Descriptive, Prescriptive), Application (Marketing, R&D, Compliance, SCM), Component (Software, ... CRO) - Forecasts to 2021" published by MarketsandMarkets, the market is ... Billion in 2016, at a CAGR of 13.3% during the forecast ... ...
Breaking Medicine Technology:
(Date:1/23/2017)... ... ... “The Inn at the Mill”: a story of love and redemption, hope and uncertainty ... and content. , “The Inn at the Mill” is the creation of published author, ... and is now living in Berks County on Crow Hill. The inn, the ...
(Date:1/23/2017)... ... ... a time when many people celebrate romance and love by giving cards, candy, flowers or ... present, Atlanta-based Perimeter Plastic Surgery is offering a Valentine’s Day special: Spend $100 ... $50 free. , “A lot of people just buy the more predictable gift of ...
(Date:1/21/2017)... FL (PRWEB) , ... January 21, 2017 , ... Caronlab ... recently attended the January ECRM Trade Show in Hilton Head, SC, where it benefited ... reputation for the quality of its beauty and wellness products. At this trade show, ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual meeting ... family, friends, and community. “Coming Home 2017” will be held on Friday ...
(Date:1/20/2017)... MT (PRWEB) , ... January 20, 2017 , ... Spectrum Aquatics Launches New ADA Portable ... saving deck space. Since the lift is mounted on wheels, it can be wheeled out ... lock down kit, to fasten to the deck. "We have transformed the feedback from customers ...
Breaking Medicine News(10 mins):